Categories
Change Password!
Reset Password!
Only a few antibiotics consistently demonstrate adequate target-site exposure in bone and joint infections, spotlighting an important obstacle in optimizing patient outcomes.
The effectiveness of antibiotic therapy is frequently judged by the dose prescribed, but for patients with bone and joint infections (BJI), the more important question may be whether enough drug reaches the infected tissue. Recognizing this gap in knowledge, researchers analyzed the scientific literature to explore the relationship between antibiotic concentrations at infection sites and the microbiological targets necessary for successful treatment.
To uncover what is known about antibiotic exposure at the site of infection, the team carried out an extensive review of human studies investigating drug concentrations in bone tissue and synovial fluid. They compiled detailed information on patient populations, antibiotic dosing strategies, sampling procedures, analytical testing methods, and measured drug levels in both tissues and blood. These findings were then assessed against epidemiological cutoff values (ECOFFs), allowing the researchers to evaluate whether reported concentrations were likely to reach levels capable of inhibiting clinically relevant pathogens. Where sufficient evidence existed, tissue concentration data were visually mapped against bacterial susceptibility thresholds to identify potential patterns in target-site exposure.
The findings suggested that reaching the infection site may be more predictable for some antibiotics than others. Among the drugs evaluated, ciprofloxacin, cefazolin, cefuroxime, vancomycin, and linezolid generally achieved tissue exposure levels compatible with bacterial inhibition when standard dosing strategies were used. However, the overall body of evidence remained surprisingly thin, and substantial variability in reported concentrations combined with limited data for many agents; prevented firm conclusions about the performance of several commonly prescribed antibiotics.
Although a few antibiotics appeared to achieve adequate target-site exposure, the overall evidence base remained limited and inconsistent. They concluded that stronger clinical and pharmacological data are needed to optimize antibiotic selection and dosing in BJIs.
Expert Opinion on Drug Metabolism & Toxicology
The mysteries of target site concentrations of antibiotics in bone and joint infections: what is known? A narrative review
Birgit C P Koch et al.
Comments (0)